Lazard Opportunistic Strategies Portfolio XBI Holdings History
Lazard Opportunistic Strategies Portfolio's SPDR Biotech ETF Holding Summary
As of 2025-03-31, LAZARD FUNDS INC held - shares of SPDR Biotech ETF(XBI), totaling N/A. This investment constitutes 0% of their stock portfolio, and LAZARD FUNDS INC now holds 0% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2024Q3. And since then Lazard Opportunistic Strategies Portfolio has made 1 purchases of XBI, at an average price of $98.25, for a total of 6,582.00 shares. In addition, there have been 2 sales at an average price of $89.75 for 6,582.00 shares. Based on historical transaction data and XBI's current price of $87.37, Lazard Opportunistic Strategies Portfolio's estimated gain on his XBI holdings is $-55,963.07, reflecting a -8.65% gain to date.
Lazard Opportunistic Strategies Portfolio XBI ($87.37) Holding Chart
Lazard Opportunistic Strategies Portfolio XBI ($87.37) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
